Independent Financial Group LLC Buys Shares of 191,222 Sabra Healthcare REIT, Inc. $SBRA

Independent Financial Group LLC bought a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) during the 1st quarter, HoldingsChannel reports. The firm bought 191,222 shares of the real estate investment trust’s stock, valued at approximately $3,677,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in SBRA. Rothschild Investment LLC increased its position in shares of Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 889 shares in the last quarter. Smartleaf Asset Management LLC lifted its holdings in Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares in the last quarter. Strengthening Families & Communities LLC bought a new position in Sabra Healthcare REIT during the fourth quarter worth about $29,000. Danske Bank A S acquired a new position in Sabra Healthcare REIT in the third quarter valued at about $30,000. Finally, Larson Financial Group LLC grew its stake in Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 553 shares during the period. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Price Performance

SBRA stock opened at $20.11 on Friday. The stock has a 50-day moving average price of $19.60 and a two-hundred day moving average price of $19.74. The stock has a market cap of $5.07 billion, a PE ratio of 31.92, a price-to-earnings-growth ratio of 1.50 and a beta of 0.65. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT, Inc. has a 1 year low of $17.17 and a 1 year high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.16. The firm had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The company’s revenue for the quarter was up 20.9% on a year-over-year basis. During the same quarter last year, the business posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.0%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 190.48%.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the company. Truist Financial raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $22.00 price target on the stock in a research report on Wednesday, July 8th. Weiss Ratings lowered Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Barclays started coverage on Sabra Healthcare REIT in a research note on Tuesday, July 7th. They set an “overweight” rating and a $21.00 target price for the company. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Finally, UBS Group cut their price target on shares of Sabra Healthcare REIT from $22.00 to $21.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 8th. Five investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $21.45.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.